STIM Neuronetics Inc

Neuronetics Inc is a commercial stage medical technology company. It is focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.

$4.15  +0.25 (6.41%)
As of 12/02/2021 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  06/28/2018
Outstanding shares:  26,367,959
Average volume:  238,460
Market cap:   $102,835,040
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    64131A105
ISIN:        US64131A1051
Sedol:      BFXH9H2
Valuation   (See tab for details)
PE ratio:   -4.02
PB ratio:   1.20
PS ratio:   1.84
Return on equity:   -29.88%
Net income %:   -48.71%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy